Accumulating evidence has shown SMN depletion to effect other CNS compartments, including astrocytes, microglia, and neurons [18–21], as well as peripheral tissues, contributing to the progression of disease in SMA patients and in pre-clinical models [22,23]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.